ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Clinical Practice Session

Out of Sight, Not out of Mind: Mood Disorders in the Dialysis Unit

November 08, 2019 | 10:30 AM - 12:30 PM

Location: 146 A/B, Walter E. Washington Convention Center

Session Description

Mood disorders are common among individuals on dialysis, but nephrologists often do not have up-to-date training in the diagnosis and management of these conditions. As the depression measure enters the US ESRD Quality Incentive Program, detection rates are poised to rise, and professionals must be equipped to manage patients appropriately. In addition, there may be special cardiovascular safety considerations when prescribing medications to treat mood disorders in this complex population.

Learning Objective(s)

  • Describe a patient’s perspective on mental health disorders in dialysis
  • Formulate an approach to the management of depression among individuals receiving dialysis
  • Formulate an approach to the management of anxiety among individuals receiving dialysis
  • Discuss potential risks of pharmacologic approaches to management of mental health disorders in the dialysis population

Learning Pathway(s)

  • Dialysis

Moderators

  • Susan Hedayati, MD, MS, FASN
  • David M. White

Presentations

  • International Trends in Mood Disorders in the Dialysis Population
    10:30 AM - 11:00 AM
    Bruce M. Robinson, MD, MS, FASN 
  • Management of Depressive Disorders in the Dialysis Population
    11:00 AM - 11:30 AM
    Rajnish Mehrotra, MD, MBBS, FASN 
  • Anxiety in Dialysis: Undertreated or Overtreated?
    11:30 AM - 12:00 PM
    Daniel Cukor, PhD 
  • Cardiovascular Safety Considerations When Prescribing Mood-Related Drugs to the Dialysis Population
    12:00 PM - 12:30 PM
    Magdalene M. Assimon, PharmD, PhD